National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
In English | En español
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
Clinical Trials (PDQ®)
Patient VersionHealth Professional Version
Last Modified: 4/1/1988  
Page Options
Print This Page  Print This Page
E-Mail This Document  E-Mail This Document
Clinical Trial Questions?
Get Help:

1-800-4-CANCER or

LiveHelp online chat

Quick Links
Help Using the NCI Clinical Trials Search Form

Educational Materials About Clinical Trials

About NCI's Cancer Clinical Trials Registry

Dictionary of Cancer Terms

NCI Drug Dictionary
Related Links
Educational Materials About Clinical Trials

Clinical Trials

Questions to Ask Your Doctor

Drug Information from MedlinePlus
Phase II Differentiation Therapy with Aclacinomycin-A in Patients with Acute Leukemia and Myelodysplastic Syndromes (Summary Last Modified 04/88)

Basic Trial Information
Trial Contact Information

Basic Trial Information

PhaseTypeStatusAgeSponsorProtocol IDs
Phase IITreatmentClosed18 and overYALE-HIC-3170
NCI-V86-0107

Trial Contact Information

Trial Lead Organizations

Yale Cancer Center

Thomas Duffy, MD, Protocol chair
Ph: 203-785-4744

Back to TopBack to Top

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov